__NUXT_JSONP__("/drugs/Etaracizumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"892553-42-3",chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal IgG1 antibody directed against the vitronectin receptor alpha v beta 3 integrin. Etaracizumab blocks the binding of ligands, such as vitronectin, to alpha v beta 3 integrin, resulting in inhibition of angiogenesis and metastasis. Alpha v beta 3 integrin is a cell adhesion and signaling receptor that is expressed on the surface of tumor vessel endothelial cells, some tumor cells, and a number of other cell types.",fdaUniiCode:"41W9MFI160",identifier:"C1800",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["Abegrin","ETARACIZUMAB",a,"Humanized Monoclonal Antibody LM609","MEDI-522","Monoclonal Antibody Anti-Avb3 Integrin Medi-522","Monoclonal Antibody Anti-alpha V Beta 3 Integrin MEDI-522","Vitaxin","etaracizumab","humanized monoclonal antibody MEDI-522"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEtaracizumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Etaracizumab","","2021-10-30T13:36:40.933Z")));